Atlas Trials

A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607

Clinical trial NCT02737007 · COMPLETED

Trial details

NCT number
NCT02737007
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malaria, Falciparum
Start date
2016-04-18
Primary completion
2016-05-12
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.